Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,908
archived clinical trials in
Renal Impairment / Chronic Kidney Disease

A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Phoenician Centers for Research & Innovation (PCRI)
mi
from
Phoenix, AZ
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Phoenician Centers for Research & Innovation (PCRI)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Remington-Davis Clinical Research
mi
from
Columbus, OH
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Remington-Davis Clinical Research
mi
from
Columbus, OH
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Physician's East Endocrine Research
mi
from
Greenville, NC
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Physician's East Endocrine Research
mi
from
Greenville, NC
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Northeast Clinical Research Center, LLC
mi
from
Bethlehem, PA
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Nephrology Associates
mi
from
Chattanooga, TN
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Nephrology Associates
mi
from
Chattanooga, TN
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Mendez Center for Clinical Research LLC
mi
from
Fairfax Station, VA
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Mendez Center for Clinical Research LLC
mi
from
Fairfax Station, VA
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Gulfcoast Endocrine and Diabetes Center
mi
from
Clearwater, FL
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Gulfcoast Endocrine and Diabetes Center
mi
from
Clearwater, FL
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Kidney Care Augusta
mi
from
Augusta, GA
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Kidney Care Augusta
mi
from
Augusta, GA
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
The Warren Alpert School of Brown University
mi
from
Providence, RI
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
The Warren Alpert School of Brown University
mi
from
Providence, RI
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Jacobi Medical Center
mi
from
Bronx, NY
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Jacobi Medical Center
mi
from
Bronx, NY
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
University of Kansas Medical Center
mi
from
Kansas City, KA
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
Columbia University Medical Center - Nephrology
mi
from
New York, NY
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
Columbia University Medical Center - Nephrology
mi
from
New York, NY
Click here to add this to my saved trials
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated:  12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases - PHOENIX
A Phase 2 Trial of the Safety and Efficacy of Bardoxolone Methyl in Patients With Rare Chronic Kidney Diseases
Status: Enrolling
Updated: 12/31/1969
University of California at Los Angeles
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Status: Enrolling
Updated:  12/31/1969
Northwell Health (Division Endocrinology and Nephrology)
mi
from
Great Neck, NY
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Assessment of Glycemic Control in Patients With Type 2 Diabetes Mellitus and Late Stage Chronic Kidney Disease
Status: Enrolling
Updated: 12/31/1969
Northwell Health (Division Endocrinology and Nephrology)
mi
from
Great Neck, NY
Click here to add this to my saved trials
Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
An Open-Label Study to Investigate the Effect of Renal Impairment on the Pharmacokinectics of Tenofovir Exalidex
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Evaluation of Effect of Renal Impairment on the PK of Tenofovir Exalidex
An Open-Label Study to Investigate the Effect of Renal Impairment on the Pharmacokinectics of Tenofovir Exalidex
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
The Efficacy of "MediHoney" to Facilitate Catheter Exit-Site Surgical Wound Healing
The Efficacy of "MediHoney" to Facilitate Catheter Exit-Site Surgical Wound Healing and Prevention of Wound Bacterial Colonization: A Randomized, Open-label, Controlled, Clinical Trial
Status: Enrolling
Updated:  12/31/1969
University of Missouri Department of Medicine; Dialysis Clinic, Inc.
mi
from
Columbia, MO
The Efficacy of "MediHoney" to Facilitate Catheter Exit-Site Surgical Wound Healing
The Efficacy of "MediHoney" to Facilitate Catheter Exit-Site Surgical Wound Healing and Prevention of Wound Bacterial Colonization: A Randomized, Open-label, Controlled, Clinical Trial
Status: Enrolling
Updated: 12/31/1969
University of Missouri Department of Medicine; Dialysis Clinic, Inc.
mi
from
Columbia, MO
Click here to add this to my saved trials
Care Coordination/Home Telehealth to Safeguard Care in CKD
Care Coordination/Telehealth to Address Patient Safety and Poor Outcomes in CKD
Status: Enrolling
Updated:  12/31/1969
Baltimore VA Medical Center
mi
from
Baltimore, MD
Care Coordination/Home Telehealth to Safeguard Care in CKD
Care Coordination/Telehealth to Address Patient Safety and Poor Outcomes in CKD
Status: Enrolling
Updated: 12/31/1969
Baltimore VA Medical Center
mi
from
Baltimore, MD
Click here to add this to my saved trials
Measuring Bladder Volumes Scanning in the ICU
Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU
Status: Enrolling
Updated:  12/31/1969
Barnes-Jewish Hospital / Washington University
mi
from
Saint Louis, MO
Measuring Bladder Volumes Scanning in the ICU
Measuring Bladder Volumes With Ultrasound and Bladder Scanning in the ICU
Status: Enrolling
Updated: 12/31/1969
Barnes-Jewish Hospital / Washington University
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
An Open-label, Parallel-Group Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
An Open-label, Parallel-Group Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami
mi
from
Miami, FL
Click here to add this to my saved trials
Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
An Open-label, Parallel-Group Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
An Open-label, Parallel-Group Study to Evaluate the Pharmacokinetics of Lemborexant and Its Metabolites in Subjects With Normal Renal Function or With Severe Renal Impairment
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
An Open-label Pilot Study to Determine the Tolerability and Efficacy of Fixed-dose Grazoprevir/Elbasvir Treatment in Hepatitis C Uninfected Recipients of Renal Transplants From Hepatitis C Infected Deceased Donors
Status: Enrolling
Updated:  12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Exploring Renal Transplants Using Hepatitis C Infected Donors for HCV-negative Recipients
An Open-label Pilot Study to Determine the Tolerability and Efficacy of Fixed-dose Grazoprevir/Elbasvir Treatment in Hepatitis C Uninfected Recipients of Renal Transplants From Hepatitis C Infected Deceased Donors
Status: Enrolling
Updated: 12/31/1969
Johns Hopkins Hospital
mi
from
Baltimore, MD
Click here to add this to my saved trials
Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Phase 3, Randomized, Open Label, Active Controlled Study Evaluating the Efficacy and Safety of Three Times Per Week (TIW) Oral Dosing of Vadadustat for the Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (TRILO2GY)
Status: Enrolling
Updated:  12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Study to Evaluate Three Times Per Week (TIW) Oral Dosing of Vadadustat for Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD)
Phase 3, Randomized, Open Label, Active Controlled Study Evaluating the Efficacy and Safety of Three Times Per Week (TIW) Oral Dosing of Vadadustat for the Treatment of Anemia in Subjects With Dialysis-Dependent Chronic Kidney Disease (DD-CKD) (TRILO2GY)
Status: Enrolling
Updated: 12/31/1969
Clinical Research Facility
mi
from
Northridge, CA
Click here to add this to my saved trials
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Carolina Dialysis - Siler City
mi
from
Siler City, NC
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Carolina Dialysis - Siler City
mi
from
Siler City, NC
Click here to add this to my saved trials
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Status: Enrolling
Updated:  12/31/1969
Carolina Dialysis - Carrboro
mi
from
Carrboro, NC
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Ultrafiltration Profiling and Outcomes Among Individuals on Maintenance Hemodialysis
Status: Enrolling
Updated: 12/31/1969
Carolina Dialysis - Carrboro
mi
from
Carrboro, NC
Click here to add this to my saved trials
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
A Study to Assess the Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin Administered as Microdoses in Subjects With Varying Degrees of Renal Insufficiency in the Presence and Absence of Rifampin
Status: Enrolling
Updated:  12/31/1969
Clinical Pharmacology of Miami, Inc.
mi
from
Hialeah, FL
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
A Study to Assess the Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin Administered as Microdoses in Subjects With Varying Degrees of Renal Insufficiency in the Presence and Absence of Rifampin
Status: Enrolling
Updated: 12/31/1969
Clinical Pharmacology of Miami, Inc.
mi
from
Hialeah, FL
Click here to add this to my saved trials
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
A Study to Assess the Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin Administered as Microdoses in Subjects With Varying Degrees of Renal Insufficiency in the Presence and Absence of Rifampin
Status: Enrolling
Updated:  12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin in Participants With Renal Insufficiency in the Presence and Absence of Rifampin (MK-0000-386)
A Study to Assess the Pharmacokinetics of Midazolam, Dabigatran, Pitavastatin, Atorvastatin, and Rosuvastatin Administered as Microdoses in Subjects With Varying Degrees of Renal Insufficiency in the Presence and Absence of Rifampin
Status: Enrolling
Updated: 12/31/1969
Orlando Clinical Research Center
mi
from
Orlando, FL
Click here to add this to my saved trials
Decision-Aid for Renal Therapy Pilot Trial
Decision-Aid for Renal Therapy Pilot Trial (DART Pilot Trial)
Status: Enrolling
Updated:  12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Decision-Aid for Renal Therapy Pilot Trial
Decision-Aid for Renal Therapy Pilot Trial (DART Pilot Trial)
Status: Enrolling
Updated: 12/31/1969
Tufts Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Decision-Aid for Renal Therapy Pilot Trial
Decision-Aid for Renal Therapy Pilot Trial (DART Pilot Trial)
Status: Enrolling
Updated:  12/31/1969
St Elizabeth's Medical Center
mi
from
Brighton, MA
Decision-Aid for Renal Therapy Pilot Trial
Decision-Aid for Renal Therapy Pilot Trial (DART Pilot Trial)
Status: Enrolling
Updated: 12/31/1969
St Elizabeth's Medical Center
mi
from
Brighton, MA
Click here to add this to my saved trials
Blood Pressure Lowering in Dialysis (BOLD) Trial
BOLD: A Trial of Blood Pressure Lowering in Dialysis
Status: Enrolling
Updated:  12/31/1969
UCSF
mi
from
San Francisco, CA
Blood Pressure Lowering in Dialysis (BOLD) Trial
BOLD: A Trial of Blood Pressure Lowering in Dialysis
Status: Enrolling
Updated: 12/31/1969
UCSF
mi
from
San Francisco, CA
Click here to add this to my saved trials
Blood Pressure Lowering in Dialysis (BOLD) Trial
BOLD: A Trial of Blood Pressure Lowering in Dialysis
Status: Enrolling
Updated:  12/31/1969
Univ of Washington
mi
from
Seattle, WA
Blood Pressure Lowering in Dialysis (BOLD) Trial
BOLD: A Trial of Blood Pressure Lowering in Dialysis
Status: Enrolling
Updated: 12/31/1969
Univ of Washington
mi
from
Seattle, WA
Click here to add this to my saved trials
Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
Open-label, Parallel-group, Drug-drug Interaction Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
Status: Enrolling
Updated:  12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
Open-label, Parallel-group, Drug-drug Interaction Study in End-stage Renal Disease Patients Awaiting Kidney Transplant to Investigate the Potential Effect of IVIG Treatment on the Pharmacokinetics and Pharmacodynamics of LFG316
Status: Enrolling
Updated: 12/31/1969
Novartis Investigative site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Solaris Clinical Research
mi
from
Meridian, ID
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Solaris Clinical Research
mi
from
Meridian, ID
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Carl R. Meisner Medical Clinic
mi
from
Sugar Land, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Carl R. Meisner Medical Clinic
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Torrance Clinical Research Institute Inc.
mi
from
Lomita, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Valley Clinical Trials
mi
from
Northridge, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Valley Clinical Trials
mi
from
Northridge, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Endocrine Associates of Florida, P.A.
mi
from
Ocoee, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Endocrine Associates of Florida, P.A.
mi
from
Ocoee, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Aa Mrc Llc
mi
from
Flint, MI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Juno Research
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Juno Research
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Manassas Clinical Research Center
mi
from
Manassas, VA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Manassas Clinical Research Center
mi
from
Manassas, VA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
San Marcus Research Clinic
mi
from
Miami Lakes, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
San Marcus Research Clinic
mi
from
Miami Lakes, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Leon Medical Research
mi
from
Miami, FL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Leon Medical Research
mi
from
Miami, FL
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Cotton-O'Neil Clinical Research Center
mi
from
Topeka, KA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Rockwood Medical Clinic
mi
from
Fort Worth, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Rockwood Medical Clinic
mi
from
Fort Worth, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Endocrine Associates
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Endocrine Associates
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Pioneer Research Solutions, Inc.
mi
from
Houston, TX
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Diabetes Associates Medical Group
mi
from
Orange, CA
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Diabetes Associates Medical Group
mi
from
Orange, CA
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
East-West Medical Research Institute
mi
from
Honolulu, HI
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
East-West Medical Research Institute
mi
from
Honolulu, HI
Click here to add this to my saved trials
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated:  12/31/1969
Associated in Endocrinology
mi
from
Elgin, IL
Phase 2 Study of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
A Randomized, Placebo-Controlled, Double-Blind, Multicenter, Phase 2 Study to Assess Safety, Tolerability, and Renal Effects of TMX-049 in Subjects With Type 2 Diabetes and Albuminuria
Status: Enrolling
Updated: 12/31/1969
Associated in Endocrinology
mi
from
Elgin, IL
Click here to add this to my saved trials